Butyric acid has been known to inhibit growth and to induce differentiation
of a variety of tumor cells. Butyrate-treated tumor cells have also been o
bserved to undergo apoptosis. Although butyrate compounds have demonstrated
antitumor activity in murine tumor models and have already been admitted t
o clinical trials in tumor patients, the exact mechanism of their antitumor
effects has not been elucidated. The results of our study showed antitumor
activity of tributyrin, a butyric acid prodrug, in murine melanoma model a
nd are strongly suggestive that antiangiogenic effects could participate in
antitumor effects of butyrate compounds in vivo. (C) 2001 Elsevier Science
Ireland Ltd. All rights reserved.